Why NeuBase Therapeutics Popped by 16.5% on Friday

Eric Volkman, The Motley Fool
·2-min read
Why NeuBase Therapeutics Popped by 16.5% on Friday

NeuBase Therapeutics (NASDAQ: NBSE) ended the week on a real sugar high, rising by nearly 17% on Friday. The praise came from Greenlight Capital, the hedge fund run by noted investor David Einhorn. On Thursday, Greenlight released the latest quarterly update on its performance.